High materiality7/10
Biogen price target lowered to $256 from $260 at RBC Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC lowers BIIB target to $256 from $260; current price about $219.91, still above target but upside remains.
- RBC lowers BIIB target to 256; price 219.91
Key facts
- 01
Target: $256
- 02
Posted price: $219.91
- 03
Analyst firm: RBC Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.